A core feature of the Global Training Hub for Biomanufacturing (GTH-B) program is providing training and consulting services on-site at vaccine research institutes and manufacturing facilities in low- and middle-income countries. IVI conducted the first of these sessions with Incepta in Bangladesh last year followed by a second session with Afrigen Biologics & Vaccines (Afrigen) in South Africa. Led by subject experts from IVI, these trainings provide comprehensive overviews and practical applications of key aspects of biomanufacturing, including the production of vaccines and therapeutics.
In May and June of this year, a team of IVI trainers led sessions at the Kenya Medical Research Institute (KEMRI) and Kenya BioVax Institute in Nairobi as well as Institut Pasteur de Dakar (IPD) in Senegal. The trainings spanned the gamut of vaccine development production, including vaccine discovery and early clinical development, clinical trial design, aseptic processing, pharmaceutical quality systems, intellectual property and patent systems, vaccine process development, and technology transfer in addition to best practices in business development and project management.